HOME > BUSINESS > AstraZeneca Pfizer deal to hit Indian unit due to the loss of Meronem

AstraZeneca Pfizer deal to hit Indian unit due to the loss of Meronem

meronemAstraZeneca Pharma India said AstraZeneca UK has asked to terminate its existing distribution arrangements for Meronem (meropenem) in India.

“This is as a result of a global agreement by AstraZeneca PLC to sell the development and commercialisation rights to Pfizer Inc, of its late-stage small molecule antibiotics business,” the company said.

Separately, its global parent announced that it has entered into an agreement with Pfizer Inc to sell the commercialisation and development rights to its late-stage small molecule antibiotics business in most markets globally outside the US.

Meronem is a carbapenem anti-bacterial used for the treatment of serious infections in hospitalised patients. The drug is currently one of the Indian unit’s principal products and generated 18% of the total turnover of the company in the financial year ended 31 March 2016.

“The current distribution arrangements for Meronem in India will terminate in six months from today, as per notice dated August 24, 2016 received by the Company from AstraZeneca UK Limited,” it added.

The global transaction between AstraZeneca PLC and Pfizer Inc. is expected to close in the fourth quarter of the year 2016, subject to customary closing conditions, it added.

Follow ULTRA.news
Reliance Communications says MTS merger to be closed in 2 weeks, gets DoT nod Reliance Communication Ltd said it received the approval of Department of Telecommunication (DoT) for its merger with Sistema Shyam Teleservices Limited or SSTL, which runs MTS branded services in India.With this, the Anil Ambani Group company has received all the major regu...
XL Catlin to buy 20% of Mahindra Insurance Brokers Mahindra Finance said global insurance major XL Group will take a 20% stake in its subsidiary Mahindra Insurance Brokers Ltd, including the 15% currently held by LeapFrog Financial Inclusion Fund."XL Group will help support MIBL’s endeavours to increase insurance awareness a...
Bharti Airtel merges Ghana arm with Tigo of Millicom Bharti Airtel said it is merging its operations in the African nation of Ghana with the local unit of Millicom International Cellular."Under the joint agreement, Airtel and Millicom will have equal ownership (50:50) and governance rights in the combined entity, which will ha...
Tata Tele acquisition good for Bharti Airtel – Fitch Bharti Airtel Limited's (BBB-/Stable) announcement that it plans to acquire the consumer mobile operations of Tata Teleservices and Tata Teleservices (Maharashtra) Ltd (Tata Telecom business) is positive for the deal participants as well as the industry, Fitch Ratings said.B...
Tata Teleservices to merge mobile business with Bharti Airtel Bharti Airtel Limited, India’s largest telecommunications services provider and Tata, India’s leading conglomerate, today announced that they have entered into an understanding to merge Consumer Mobile Businesses (CMB) of TTSL and TTML into Bharti Airtel.The move is likely ...
Lupin buys US-based vaginosis drug maker for $150 mln Pharma major Lupin said that its US subsidiary, Lupin, Inc has acquired Symbiomix Therapeutics, LLC for a cash consideration of USD 150 million including a USD 50 million upfront and other time‐based payments.In addition, there are sales based contingent payments.Lupin h...
Reliance Infrastructure in talks to sell Mumbai power network to Adani Reliance Infrastructure said it has entered exclusive negotiations with Adani Transmission Limited for the sale of its power distribution business in Mumbai.The deal involves its integrated business of generation, transmission and distribution of power for Mumbai City, the A...
Suven Life Sciences gets patent for neuro drug Suven Life Sciences Ltd said it was granted a patent by New Zealand authorities for "a class of selective 5-HT4 compounds" that are being developed to treat neurodegenerative diseases.The compounds are being explored for use in cases of Alzheimer’s disease, Attention deficie...
USFDA returns Mylan-Biocon’s drug application for more data The U.S. Food and Drug Administration has sought more data before approving a chemotherapy compound submitted by Mylan and jointly developed by Biocon.The agency issued a 'complete response letter'. Such letters are issued when an FDA review an FDA review finds that an appli...
Crompton Greaves says no binding deal with Videocon on Kenstar acquisition Crompton Greaves, one of India's biggest electrical durables makers, said it has not executed any binding transaction documents with Videocon Industries on the acquisition of the Kenstar brand in India.Responding to a report in the Economic Times that said a binding offer at...
Future Retail to pay Rs 500 cr in stock, 155 cr cash for Hypercity Future Retail will pay most of the cost of its proposed Hypercity acquisition by issuing new shares, and only about a fourth will be paid in cash.The deal will put even more distance between Future, which operates chains such as Big Bazaar and Central, and other players in I...
Wipro acquires 25-year-old US-based design consultancy Cooper Wipro said it has agreed to acquire US-based design consultancy Cooper, without disclosing the financial details."Headquartered in San Francisco, Cooper has been a leading brand in interaction design, UX and professional design education for more than 25 years," the Indian I...
RCom withdraws scheme for sale of tower co to Brookfield Reliance Communications said it has filed with the National Company Law Tribunal to withdraw its demerger scheme for its tower assets.The move follows the cancellation of its plans to merge with Aircel Cellular due to regulatory issues.The company Anil Ambani-led company...
NATCO Pharma to sell multiple sclerosis drug in USA via Mylan NATCO Pharma Limited said it the US Food and Drug Administration approved the generic drug application filed by its marketing partner Mylan for injections used in the treatment of multiple sclerosis, a chronic inflammatory disease of the central nervous system.The drug, Glat...
Cyient ties up with US start-up to incorporate AI tech in power solution Mumbai-based IT services provider Cyient said it has signed an agreement to incorporate machine learning meter and voltage signature technology from US-based startup Elpis in its solutions for power utilities."Through this agreement, Cyient and Elpis will jointly pursue util...
Apollo Tyres refutes Economic Times report on Kumho acquisition Apollo Tyres said it 'strongly denies' the Economic Times report that it was trying to acquire South Korea's No. 2 tyre maker Kumho Tire for $900 million."Apollo Tyres strongly denies the story headlined 'Apollo Back in Kumho Race as Geopolitics Sours China Deal’ that appear...
Is Reliance Jio about to acquire Den Networks? Reliance Industries refused to deny or confirm media reports about its telecom unit Jio being in talks to acquire cable operator Den Networks.Shares of Den Networks, one of India's largest cable networks, are up 6.2%, having opened higher on the news."We are unable to co...
Infosys to deliver private cloud solution based on Suse Linux and Openstack IT services provider Infosys said it now offers a private cloud solution built using SUSE Linux and Openstack.The solution will make use of Openstack cloud and datacenter solutions developed by Germany-based Micro Focus SUSE.Infosys and Micro Focus SUSE have jointly inve...
Vivimed pharma unit gets Rs 270 cr investment from OrbiMed fund Pharmaceuticals and specialty chemicals maker Vivimed Labs said investment firm OrbiMed will invest $42.5 mn (Rs 270 cr) into its active pharmaceutical ingredients business.The investment will be into Vivimed Labs Mascarene Ltd, which is in turn the holding entity of the com...
Tata Capital sells Travel & Forex business to Thomas Cook Thomas Cook, the travel services company, said it had purchased the forex business of Tata Capital, Tata Capital Forex, in its entirety."We would like to inform you that the Board of Directors of the Company at their Meeting held on 25th September, 2017, approved the acquisi...